a year ago
SDGR
AnalystsDavid LebovitzDavid Lebovitz's Stock Forecasts
AnalystsDavid Lebovitz
Analyst Ranking
Bottom 10%
#4153 out of 4565 analysts
Average Return
-3.94%
Win Rate
34%26 out of 77
Risk vs Reward
Poor
Good
David Lebovitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Clementia Pharmaceuticals IncCMTA | +202.87% | $8.70 | $26.35 | 2018-08-13 - 2019-04-17 | Strong Buy |
Avexis IncAVXS | +129.75% | $94.81 | $217.83 | 2017-08-03 - 2018-05-15 | Strong Buy |
Avexis IncAVXS | +124.59% | $96.99 | $217.83 | 2017-11-13 - 2018-05-15 | Strong Buy |
Ascendis Pharma AASND | +107.40% | $71.19 | $147.65 | 2023-04-05 - 2024-04-04 | Strong Buy |
Epizyme IncEPZM | +72.91% | $5.50 | $1.49 | 2021-08-10 - 2022-08-09 | Strong Sell |
David Lebovitz Analyst Color
Get additional color on David Lebovitz's coverage of popular stocks
a year ago
PLRX
a year ago
ASND
David Lebovitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biomarin Pharmaceutical IncBMRN | 4 | Hold | $91.00 | +10.75% | Maintains | a day ago |
Madrigal Pharmaceuticals IncMDGL | 2 | Strong Buy | $389.00 | +100.12% | Maintains | a month ago |
Crinetics Pharmaceuticals IncCRNX | 1 | Strong Buy | $68.00 | +60.79% | Initiates Coverage On | 2 months ago |
Schrodinger IncSDGR | 6 | Strong Buy | $39.00 | +67.10% | Maintains | 2 months ago |
Cogent Biosciences IncCOGT | 2 | Strong Buy | $13.00 | +116.31% | Maintains | 2 months ago |
Bridgebio Pharma IncBBIO | 2 | Strong Buy | $46.00 | +89.07% | Maintains | 2 months ago |
Blueprint Medicines CorpBPMC | 6 | Strong Sell | $65.00 | -28.36% | Maintains | 2 months ago |
Alnylam Pharmaceuticals IncALNY | 20 | Strong Buy | $227.00 | +57.96% | Maintains | 2 months ago |
Incyte CorpINCY | 2 | Strong Buy | $81.00 | +58.26% | Maintains | 2 months ago |
Ascendis Pharma AASND | 9 | Strong Buy | $182.00 | +32.91% | Maintains | 3 months ago |
Exelixis IncEXEL | 1 | Strong Buy | $31.00 | +31.75% | Initiates Coverage On | 4 months ago |
Ptc Therapeutics IncPTCT | 6 | Strong Sell | $17.00 | -33.31% | Downgrades | 6 months ago |
Ionis Pharmaceuticals IncIONS | 9 | Strong Buy | $60.00 | +43.40% | Upgrades | 9 months ago |
Pliant Therapeutics IncPLRX | 3 | Strong Buy | $50.00 | N/A | Maintains | a year ago |
Intellia Therapeutics IncNTLA | 2 | Hold | $39.00 | N/A | Upgrades | a year ago |
Mirum Pharmaceuticals IncMIRM | 2 | Strong Buy | $34.00 | N/A | Maintains | a year ago |
Immuneering CorpIMRX | 2 | Hold | $12.00 | N/A | Maintains | 2 years ago |
Arcutis Biotherapeutics IncARQT | 5 | Strong Buy | $36.00 | N/A | Maintains | 2 years ago |
Syndax Pharmaceuticals IncSNDX | 1 | Hold | $21.00 | N/A | Maintains | 3 years ago |
Karyopharm Therapeutics IncKPTI | 2 | Strong Buy | $27.00 | N/A | Maintains | 3 years ago |
Ironwood Pharmaceuticals IncIRWD | 5 | Hold | $14.00 | N/A | Maintains | 3 years ago |
Avrobio IncAVRO | 3 | Strong Buy | $25.00 | N/A | Maintains | 3 years ago |
Epizyme IncEPZM | 2 | Strong Sell | $5.00 | N/A | Downgrades | 3 years ago |
Rhythm Pharmaceuticals IncRYTM | 2 | Strong Buy | $57.00 | N/A | Maintains | 3 years ago |
Macrogenics IncMGNX | 1 | Strong Sell | $15.00 | N/A | Maintains | 3 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Hold | $220.00 | N/A | Downgrades | 3 years ago |
Nabriva Therapeutics PLCNBRVF | 2 | Hold | $500.00 | N/A | Maintains | 3 years ago |
Zealand Pharma AZEAL | 1 | Strong Buy | $37.00 | N/A | Maintains | 4 years ago |
Clementia Pharmaceuticals IncCMTA | 2 | Strong Buy | $26.00 | N/A | Maintains | 6 years ago |
Avexis IncAVXS | 3 | Strong Buy | $129.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.